Acinetobacter baumannii multidrug-resistant strain occurrence in liver recipients with reference to other high-risk

I Netsvyetayeva1, M Sikora, M Golas

  • 1Department of Medical Microbiology, Warsaw Medical University, and Regional Hospital of Traumatology, St Anna, Warsaw, Poland. irenanets@gmail.com

Abstract

Insights

Acinetobacter baumannii exhibits significant multidrug resistance. This study found OXA51 genes in most strains, with some also carrying OXA23 or OXA24, indicating complex resistance mechanisms in hospital-acquired infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii is a significant pathogen due to its environmental survival, inherent multidrug resistance, and rapid development of resistance.
  • Antibiotic pressure drives the evolution of diverse resistance mechanisms in A. baumannii.

Purpose of the Study:

  • To investigate the prevalence of carbapenemase-encoding genes in Acinetobacter baumannii strains.
  • To characterize the antimicrobial resistance profiles of A. baumannii isolates from postoperative infections.

Main Methods:

  • Identification of 16 A. baumannii strains from postoperative infections.
  • Polymerase chain reaction (PCR) analysis for carbapenemase genes (VIM, IMP, SPM, OXA23, OXA24, OXA51, OXA58).
  • Phenotypic testing using double-disk synergy and antimicrobial susceptibility testing.

Main Results:

  • No metallo-beta-lactamase-producing strains were detected phenotypically or by PCR for VIM, IMP, and SPM genes.
  • All strains were susceptible to colistin. Resistance to imipenem and/or meropenem was observed in some strains, particularly from liver recipients and cancer patients.
  • Fifteen of 16 strains harbored the OXA51 gene; some also carried OXA23 or OXA24 genes, suggesting diverse carbapenemase gene carriage.

Conclusions:

  • A. baumannii strains in this cohort primarily carried OXA-type carbapenemase genes, with OXA51 being highly prevalent.
  • The absence of VIM, IMP, and SPM genes suggests a different resistance mechanism profile.
  • Understanding these genetic determinants is crucial for managing A. baumannii infections and guiding treatment strategies.